Health
Monoclonal antibodies can help high-risk people with COVID-19. But getting the drug to patients remains challe – The Philadelphia Inquirer
Demand for the drugs, which are the only approved treatment for high-risk patients who don’t need to be in the hospital, is lower than expected.
Back in December, the big worry about two newly approved treatments for early COVID-19 was that demand would far outstrip supply.
After all, some famous men had taken monoclonal antibodies after they were infected in the fall some of them before the drugs received emergency-use authorization and became highly visible converts.
Former President Donald Trump called a drug made by Regeneron a cure. (He was also given other treatments that may have helped him recover.) Ben Carson, former secretary of…
-
Noosa News20 hours agoExperts share tiny home warning as interest from young people soars
-
Noosa News19 hours agoExpert’s warning as tourists stunned by hundreds of sharks spotted close to shore at Moreton Island, Queensland
-
General16 hours agoConvicted mushroom murderer Erin Patterson outlines her reasons to appeal
-
General20 hours agoSave $200 on KitchenAid stand mixer with special accessories